Skip to main content
SpringerLink
Log in

Surgical Resection for Hepatoblastoma—Updated Survival Outcomes

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Background

Hepatoblastoma is the most common liver malignancy in the pediatric age group. The management of hepatoblastoma involves multidisciplinary approach.

Methods

Patients with hepatoblastoma who underwent liver resection between 2000 and 2013 were analyzed and survival outcomes were studied.

Results

The crude incidence rate of hepatoblastoma at the Madras Metropolitan Tumor Registry (MMTR) is 0.4/1,00,000 population per year. Twelve patients underwent liver resection for hepatoblastoma during the study period; this included eight males and four females. The median age at presentation was 1.75 years (Range 5 months to 3 years). The median serum AFP in the study population was 20,000 ng/ml (Range 4.5 to 1,40,000 ng/ml). Three patients had stage I, one patient had stage II, and eight patients had stage III disease as per the PRETEXT staging system. Two patients were categorized as high risk and ten patients were categorized as standard risk. Seven of these patients received two to four cycles of neoadjuvant chemotherapy (PLADO regimen), and one patient received neoadjuvant radiation up to 84 Gy. Major liver resection was performed in nine patients. Nine patients received adjuvant chemotherapy. The most common histological subtype was embryonal type. Microscopic margin was positive in three cases. One patient recurred 7 months after surgery and the site of failure was the lung. The 5-year overall survival of the case series was 91%. The median survival was 120 months.

Conclusion

Liver resections can be safely performed in pediatric populations after neoadjuvant treatment. Patients undergoing surgery had good disease control and long-term survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Malogolowkin MH, Katzenstein HM, Meyers RL, Krailo MD, Rowland JM, Haas J, et al. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the children’s oncology group. J Clin Oncol. 2011;29(24):3301–6.

    Article  Google Scholar 

  2. Misick OS. A case of teratoma hepatis. J Pathol Bacteriol. 1898;5:128–37.

    Article  Google Scholar 

  3. Willis RA. Some uncommon and recently identified tumours. In: Cameron R, Payling Wright G, editors. The pathology of the tumors of children. Charles C. Thoma: Springfield; 1962. p. 57–61.

    Google Scholar 

  4. Daniel C Aronson, MD, PhD, Piotr Czauderna, Rudolf Maibach, Giorgio Perilongo, and Bruce Morland. (2014) The treatment of hepatoblastoma: its evolution and the current status as per the SIOPEL trials. J Indian Assoc Pediatr Surg 19(4): 201–207.

    Article  Google Scholar 

  5. Czauderna P, Otte JB, Aronson DC, Gauthier F, Mackinlay G, Roebuck D, et al. Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Guidelines for surgical treatment of hepatoblastoma in the modern era—recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer. 2005;41(7):1031–6.

    Article  Google Scholar 

  6. MacKinlay GA, Pritchard J. A common language for childhood liver tumours. Pediatr Surg Int. 1992;7:325–6.

    Article  Google Scholar 

  7. Pritchard J, Brown J, Shafford E, et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach—results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol. 2000;18:3819–28.

    Article  CAS  Google Scholar 

  8. Suita S, Tajiri T, Takamatsu H, Mizote H, Nagasaki A, Inomata Y, et al. Committee for Pediatric Solid Malignant Tumors in the Kyushu area, Japan. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen—a report from the study group for pediatric solid malignant tumors in the Kyushu area. J Pediatr Surg. 2004;39(2):195–8. discussion 195-8

    Article  CAS  Google Scholar 

  9. Sasaki F, Matsunaga T, Iwafuchi M, Hayashi Y, Ohkawa H, Ohira M, Okamatsu T, Sugito T, Tsuchida Y, Toyosaka A, Nagahara N, Nishihira H, Hata Y, Uchino J, Misugi K, Ohnuma N; (Japanese Study Group for Pediatric Liver Tumor). Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: a report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg. 2002;37(6):851–6.

    Article  Google Scholar 

  10. Aronson DC, Schnater JM, Staalman CR, Weverling GJ, Plaschkes J, Perilongo G, et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol. 2005;23(6):1245–52.

    Article  Google Scholar 

  11. Moon S-B, Shin H-B, Seo J-M, Lee S-K. Hepatoblastoma: 15-year experience and role of surgical treatment. J Korean Surg Soc. 2011;81(2):134–40.

    Article  Google Scholar 

  12. Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2009;53(6):1016–22.

    Article  Google Scholar 

  13. Benoist S, Nordlinger B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol. 2009;16(9):2385–90.

    Article  Google Scholar 

  14. Richard M, Conran CL, Hitchcock MA, Waclawiw J, Stocker T, Ishak KG. Hepatoblastoma: the prognostic significance of histologic type. Paediatric Pathology. 1992;12(2)

  15. Davies JQ, de la Hall PM, Kaschula RO, Sinclair-Smith CC, Hartley P, Rode H, et al. Hepatoblastoma—evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases. J Pediatr Surg. 2004;39(9):1321–7.

    Article  CAS  Google Scholar 

  16. Shi Y, Commander SJ, Masand PM, Heczey A, Goss JA, Vasudevan SA. Vascular invasion is a prognostic indicator in hepatoblastoma. J Pediatr Surg. 2017; https://doi.org/10.1016/j.jpedsurg.2017.03.017.

    Article  Google Scholar 

  17. Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer. 2002;94(4):1111–20.

    Article  Google Scholar 

  18. Fuchs J, Rydzynski J, Hecker H, Mildenberger H, Bürger D, Harms D, V Schweinitz D; (2002) German Cooperative Liver Tumour Studies HB 89 and HB 94. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma—a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94. Eur J Pediatr Surg 12(4):255–261.

    Article  CAS  Google Scholar 

  19. Ang JP, Heath JA, Donath S, Khurana S, Auldist A. Treatment outcomes for hepatoblastoma: an institution’s experience over two decades. Pediatr Surg Int. 2007;23(2):103–9. Epub 2006 Nov 21

    Article  CAS  Google Scholar 

  20. Shanmugam N, Scott JX, Kumar V, Vij M, Ramachandran P, Narasimhan G, et al. Multidisciplinary management of hepatoblastoma in children: experience from a developing country. Pediatr Blood Cancer. 2017;64(3) https://doi.org/10.1002/pbc.26249.

    Article  Google Scholar 

  21. Yada K, Ishibashi H, Mori H, Sato H, Shimada M. The role of surgical treatment in the multidisciplinary therapy for hepatoblastoma. Hepato-Gastroenterology. 2014;61(131):553–6.

    PubMed  Google Scholar 

  22. Malek MM, Shah SR, Atri P, Paredes JL, DiCicco LA, Sindhi R, et al. Review of outcomes of primary liver cancers in children: our institutional experience with resection and transplantation. Surgery. 2010;148(4):778–782; discussion 782-4. https://doi.org/10.1016/j.surg.2010.07.021.

    Article  PubMed  Google Scholar 

  23. Hou JY, Liu HC, Yeh TC, Chen SH, Wang LY, Sheu JC, et al. Long-term treatment results of hepatoblastoma at a single institution in Taiwan. J Pediatr Hematol Oncol. 2009;31(10):718–22. https://doi.org/10.1097/MPH.0b013e3181b6db88.

    Article  PubMed  Google Scholar 

  24. Towu E, Kiely E, Pierro A, Spitz L. Outcome and complications after resection of hepatoblastoma. J Pediatr Surg. 2004;39:199–202. discussion 199-202

    Article  CAS  Google Scholar 

  25. Teran DA, Beltran OG, Bru RC, González EM, Rosa MJP, Molina AL, et al. Efficacy of neoadjuvant therapy and surgical rescue for locally advanced hepatoblastomas: 10 year single-center experience and literature review. World J Gastroenterol. 2014;20(29):10137–43.

    Article  Google Scholar 

  26. Tannuri ACA, Cristofani LM, Teixeira RAP, Filho VO, Tannuri U. New concepts and outcomes for children with hepatoblastoma based on the experience of a tertiary center over the last 21 years. Clinics (Sao Paulo). 2015;70(6):387–92.

    Article  Google Scholar 

  27. Tsay P-K, Lai J-Y, Yang C-P, Hung I-J, Hsueh C, Tsai M-H, et al. Treatment outcomes for hepatoblastoma: experience of 35 cases at a single institution. J Formos Med Assoc. 2011;110(5):322–5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Cancer Institute (WIA), Adyar, Chennai, India

    Bhanu Jayanand Sunil, Ravisankar Palaniappan & Balasubramanian Venkitaraman

  2. Division of GI & HPB Oncology, Department of Surgical Oncology, Cancer Institute (WIA), No.38, Sardar Patel Road, Guindy, Chennai, PIN 600036, India

    Bhanu Jayanand Sunil

  3. Department of Biostatistics, Cancer Institute (WIA), Adyar, Chennai, India

    Rama Ranganathan

Authors
  1. Bhanu Jayanand Sunil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ravisankar Palaniappan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Balasubramanian Venkitaraman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rama Ranganathan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Bhanu Jayanand Sunil: Conception and design of work/acquisition, analysis, and interpretation of data; drafting the work and revising; final approval of the version; agreement for all aspects of the work.

Ravisankar Palaniappan: Conception and design of work/acquisition, analysis, and interpretation of data; drafting the work and revising; final approval of the version; agreement for all aspects of the work.

Balasubramanian Venkitaraman: Conception and design of work/acquisition, analysis, and interpretation of data; drafting the work and revising; final approval of the version; agreement for all aspects of the work.

Rama Ranganathan: Analysis, and interpretation of data; drafting the work and revising; final approval of the version; agreement for all aspects of the work.

Corresponding author

Correspondence to Bhanu Jayanand Sunil.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Scientific Meeting: 28th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery in Osaka, Japan. 2–4 June 2017.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sunil, B.J., Palaniappan, R., Venkitaraman, B. et al. Surgical Resection for Hepatoblastoma—Updated Survival Outcomes. J Gastrointest Canc 49, 493–496 (2018). https://doi.org/10.1007/s12029-017-0005-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-017-0005-z

Keywords

Search

Navigation